Using multiplex genome sequencing, Matsuda et al. [57] identified a higher frequency of HER2 somatic mutations such as V777L, L755S, and D769Y in IBC, especially in the HR+ subtype, compared with non-IBC patients. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.